AA
CING icon

AlphaMark Advisors’s Cingulate CING Stock Holding History

AlphaMark Advisors’s Portfolio CING Stock Details CING Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$25K Buy
5,010
+5,000
+50,000% +$21.9K 0.01% 324
2024
Q3 		$0 Buy
+10
New +$57 ﹤0.01% 707

Other funds holding CING

Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

AlphaMark Advisors's CING Position: Q4 2024 in Review

AlphaMark Advisors increased its Cingulate (CING) stake by 50,000% in Q4 2024, buying an estimated $21.9K and bringing the position to 5,010 shares worth $25K. The position accounts for 0.01% of the portfolio, ranked #324.

AlphaMark Advisors first reported a position in CING in Q3 2024 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold CING as of Q4 2024.

  • AlphaMark Advisors held 5,010 shares of Cingulate worth $25K as of Q4 2024.
  • AlphaMark Advisors bought 5,000 Cingulate shares in Q4 2024, an estimated $21.9K.
  • Cingulate made up 0.01% of AlphaMark Advisors's portfolio in Q4 2024, its #324 holding.
  • AlphaMark Advisors first reported a position in Cingulate in Q3 2024 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held Cingulate as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.